QNCX
Quince Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
QNCX Filings
Filing Date
Form Description
Form Type
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-10-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-17
Form 8-K - Current report
Key Events
2025-10-17 · Key Events
Form 8-K - Current report
2025-10-17
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-17 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-09-26
Form 8-K - Current report
Key Events
2025-09-26 · Key Events
Form 8-K - Current report
2025-08-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-08-11
Form 8-K - Current report
Key Events
2025-08-11 · Key Events
Form 8-K - Current report
2025-08-11
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-11 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
